alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.
作者信息
Carrell R W
出版信息
J Clin Invest. 1986 Dec;78(6):1427-31. doi: 10.1172/JCI112731.
Abstract
摘要
相似文献
1
alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.α1-抗胰蛋白酶：分子病理学、白细胞与组织损伤
J Clin Invest. 1986 Dec;78(6):1427-31. doi: 10.1172/JCI112731.
2
Alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症
J Hepatol. 1999;30 Suppl 1:34-9.
3
Alpha-1-antitrypsin deficiency asthma and allergy.
Eur Ann Allergy Clin Immunol. 2007 Apr;39(4):127-32.
4
The cellular basis for liver injury in alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中肝损伤的细胞基础。
Hepatology. 1991 Jan;13(1):172-85.
5
[Alpha 1-antitrypsin - clinical and forensic aspects].
Z Arztl Fortbild (Jena). 1982 Dec 15;76(24):1008-11.
6
Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症的临床特征与分子特性
Ann Allergy. 1994 Feb;72(2):105-20; quiz 120-2.
7
The molecular pathology of human alpha 1-antitrypsin.人类α1-抗胰蛋白酶的分子病理学
Biochem Soc Symp. 1984;49:55-66.
8
Determine alpha-1 antitrypsin level and phenotype in patients with neutrophilic panniculitis.测定嗜中性脂膜炎患者的α-1抗胰蛋白酶水平及表型。
J Am Acad Dermatol. 2005 Feb;52(2):373-4. doi: 10.1016/j.jaad.2004.07.033.
9
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies.实用遗传学：α-1抗胰蛋白酶缺乏症与丝氨酸蛋白酶抑制剂病
Eur J Hum Genet. 2004 Mar;12(3):167-72. doi: 10.1038/sj.ejhg.5201127.
10
Issues in the diagnosis of alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症的诊断问题
J Allergy Clin Immunol. 2008 Apr;121(4):833-8. doi: 10.1016/j.jaci.2007.12.1183. Epub 2008 Mar 4.
引用本文的文献
1
Alpha-1-antitrypsin as novel substrate for Spl proteases - implications for virulence.α-1-抗胰蛋白酶作为Spl蛋白酶的新型底物——对毒力的影响
Front Immunol. 2024 Nov 19;15:1481181. doi: 10.3389/fimmu.2024.1481181. eCollection 2024.
2
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential.α-1 抗胰蛋白酶的免疫和体内平衡途径：新的治疗潜力。
Front Immunol. 2024 Aug 19;15:1443297. doi: 10.3389/fimmu.2024.1443297. eCollection 2024.
3
Association of Serum Proteases and Acute Phase Factors Levels with Survival Outcomes in Patients with Colorectal Cancer.血清蛋白酶和急性期因子水平与结直肠癌患者生存结局的关联
Cancers (Basel). 2024 Jul 6;16(13):2471. doi: 10.3390/cancers16132471.
4
Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.静脉注射编码抗氧化人α1-抗胰蛋白酶的 AAV8 载体治疗 α1-抗胰蛋白酶缺乏症的安全性。
Hum Gene Ther. 2023 Feb;34(3-4):139-149. doi: 10.1089/hum.2022.192.
5
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke.雨蛙肽和α-1抗胰蛋白酶作为缺血性中风的新型联合疗法
Neurotherapeutics. 2022 Mar;19(2):513-527. doi: 10.1007/s13311-022-01203-0. Epub 2022 Feb 28.
6
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.丝氨酸蛋白酶抑制剂超家族及其在 COPD 和其他慢性肺部疾病中对丝氨酸蛋白酶活性的调节和功能障碍的作用。
Int J Mol Sci. 2021 Jun 14;22(12):6351. doi: 10.3390/ijms22126351.
7
Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein.循环α-1-抗胰蛋白酶蛋白的翻译后修饰。
Int J Mol Sci. 2020 Dec 2;21(23):9187. doi: 10.3390/ijms21239187.
8
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.用抗氧化的人血清白蛋白 α1-抗胰蛋白酶治疗α1-抗胰蛋白酶缺乏症。
JCI Insight. 2020 Aug 6;5(15):135951. doi: 10.1172/jci.insight.135951.
9
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease.实现诱导耐受以预防急性移植物抗宿主病。
Front Immunol. 2019 Mar 6;10:309. doi: 10.3389/fimmu.2019.00309. eCollection 2019.
10
Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment.α-1抗胰蛋白酶血液水平作为癌症治疗疗效的指标
World J Oncol. 2013 Apr;4(2):83-86. doi: 10.4021/wjon663e. Epub 2013 May 6.
本文引用的文献
1
Structure and variation of human alpha 1-antitrypsin.人类α1-抗胰蛋白酶的结构与变异
Nature. 1982 Jul 22;298(5872):329-34. doi: 10.1038/298329a0.
2
In vitro synthesis of M and Z forms of human alpha 1-antitrypsin.人α1-抗胰蛋白酶M型和Z型的体外合成
FEBS Lett. 1982 Nov 1;148(1):83-6. doi: 10.1016/0014-5793(82)81247-7.
3
4
Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.患有α1-抗胰蛋白酶缺乏症的4岁儿童。临床随访及家长对新生儿筛查的态度。
Acta Paediatr Scand. 1981 Mar;70(2):171-7. doi: 10.1111/j.1651-2227.1981.tb05537.x.
5
Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.成年慢性活动性肝炎和隐源性肝硬化患者中的杂合子MZα1-抗胰蛋白酶缺乏症。
N Engl J Med. 1981 Mar 5;304(10):557-60. doi: 10.1056/NEJM198103053041001.
6
A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor.一个包含卵清蛋白、抗凝血酶III和α1-蛋白酶抑制剂的惊人新蛋白质超家族。
Biochem Biophys Res Commun. 1980 Jul 31;95(2):864-71. doi: 10.1016/0006-291x(80)90867-0.
7
Effect of human granulocytic elastase on isolated human antithrombin III.人粒细胞弹性蛋白酶对纯化的人抗凝血酶III的作用。
Hoppe Seylers Z Physiol Chem. 1981 Feb;362(2):103-12. doi: 10.1515/bchm2.1981.362.1.103.
8
Is alpha 1-protease inhibitor inactivated by smoking?
Science. 1984 May 18;224(4650):755-6.
9
Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin.
FEBS Lett. 1983 Mar 21;153(2):270-4. doi: 10.1016/0014-5793(83)80622-x.
10
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.抗胰蛋白酶突变为抗凝血酶。α1-抗胰蛋白酶匹兹堡型（358位甲硫氨酸突变为精氨酸），一种致命的出血性疾病。
N Engl J Med. 1983 Sep 22;309(12):694-8. doi: 10.1056/NEJM198309223091203.
Zotero 插件